Orange Book product · Brand (NDA)
SEROPHENE
CLOMIPHENE CITRATE
At a glance
Mar 22, 1982
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 22, 1982
44 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
CLOMIPHENE CITRATE
Strength
50MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
NDA 018361
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- —CLOMIDBrand (NDA)
NDA 016131 · SANOFI AVENTIS US
- 2026CLOMIPHENE CITRATEGeneric (ANDA)
ANDA 220673 · ASCENT PHARMS INC
- 2025CLOMIPHENE CITRATEGeneric (ANDA)
ANDA 219781 · NOVITIUM PHARMA
- 2025CLOMIPHENE CITRATEGeneric (ANDA)
ANDA 219406 · ACCORD HLTHCARE
- 2024CLOMIPHENE CITRATEGeneric (ANDA)
ANDA 216545 · RUBICON RESEARCH
- 2024CLOMIPHENE CITRATEGeneric (ANDA)
ANDA 216739 · APPCO
- 1999CLOMIPHENE CITRATEGeneric (ANDA)
ANDA 075528 · COSETTE
- 1988MILOPHENEGeneric (ANDA)
ANDA 072196 · GRANATA BIO CORP
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
